Spotlight: An AI Method to Determine Asymptomatic COVID-19 Patients
By Ruchi Jhonsa, Ph.D. It is the year 1918. A wave of infection is spreading across the world that is killing millions of people daily. With no clue about the …
Read MoreThe Next Generation Biotech Media
By Ruchi Jhonsa, Ph.D. It is the year 1918. A wave of infection is spreading across the world that is killing millions of people daily. With no clue about the …
Read MoreBy T. Chakraborty, Ph.D. On November 2nd, CureVac announced positive interim data from their ongoing Phase 1 trial of its experimental SARS-CoV-2 vaccine, CVnCoV. The German biotech company added that …
Read MoreAs COVID-19 continues to snowball into a massive health and economic concern, the world is anxiously anticipating a vaccine. While Russia’s vaccine was approved in August, several biopharma giants worldwide …
Read MoreBy Judy Ya-Hsuan Lin On October 29th, Takeda announced its plans to supply 50 million doses of a coronavirus vaccine mRNA-1273 developed by U.S. drugmaker Moderna Inc. in the first …
Read MoreBy T. Chakraborty, Ph.D. Pharma giant Novartis is spending $69 million upfront to acquire two experimental drugs (MP0420 and MP0423) from Molecular Partners (MP) for combatting COVID-19. The drugs which …
Read MoreBy Tyler Chen As the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia and the only PIC/S GMP manufacturer of human vaccines in Taiwan, …
Read MoreBy T. Chakraborty, Ph.D. & Rajaneesh K. Gopinath, Ph.D. On October 22nd, Atea Pharmaceuticals, Inc. announced that it had entered into an arrangement with Roche for the exclusive rights to …
Read MoreBy Daniel Ojeda, Ph.D. On October 22nd, Remdesivir (Veklury) was approved by the U.S. Food and Drug Administration (FDA) to treat patients with COVID-19. The approval comes days after the …
Read MoreBy Tyler Chen On October 12th, Taiwan’s TTY Biopharm Company Limited received the authorization for delivering COVID-19 vaccines produced by BioNTech. Around 30 million vaccines will be delivered to Taiwan, …
Read MoreBy Rajaneesh K. Gopinath, Ph.D. China-based Sinovac Biotech may initiate a Phase 3 clinical trial of its inactivated COVID-19 vaccine, CoronaVac, in the Philippines as early as next month. Philippine …
Read More